Hesi Pharmacology exam 2
Hesi Pharmacology exam 2 ( 36 Questions)
A client with anemia secondary to chronic kidney disease (CKD) started a prescription for epoetin alfa two months ago. Which client finding best indicates that the medication is effective?
Reference Range
- Hemoglobin (Hgb) [Reference Range: Male: 14 to 18 g/dL (8.7 to 11.2 mmol/L)]
Hemoglobin level increased to 12 g/dL (7.45 mmol/L) might be a positive sign, but it is not the best indicator of effectiveness. Improvement in symptoms is a more reliable measure.
Epoetin alfa is a synthetic form of erythropoietin, a hormone that stimulates the production of red blood cells. In clients with anemia, especially due to CKD, epoetin alfa is given to increase the production of red blood cells and improve hemoglobin levels. The best indicator of its effectiveness is an improvement in anemia-related symptoms, such as increased energy levels and decreased fatigue, which are associated with improved oxygen-carrying capacity of the blood.
Food diary shows increased consumption of iron-rich foods may be beneficial for a client with anemia, but it is not a direct indicator of the medication's effectiveness.
Takes concurrent iron therapy without adverse effects is not a specific indicator of epoetin alfa effectiveness. Iron therapy is usually prescribed to treat iron-deficiency anemia, not anemia due to CKD.
Choice A rationale: Hemoglobin level increased to 12 g/dL (7.45 mmol/L) might be a positive sign, but it is not the best indicator of effectiveness. Improvement in symptoms is a more reliable measure.
Choice B rationale: Epoetin alfa is a synthetic form of erythropoietin, a hormone that stimulates the production of red blood cells. In clients with anemia, especially due to CKD, epoetin alfa is given to increase the production of red blood cells and improve hemoglobin levels. The best indicator of its effectiveness is an improvement in anemia-related symptoms, such as increased energy levels and decreased fatigue, which are associated with improved oxygen-carrying capacity of the blood.
Choice C rationale: A food diary shows that increased consumption of iron-rich foods may be beneficial for a client with anemia, but it is not a direct indicator of the medication's effectiveness.
Choice D rationale: Taking concurrent iron therapy without adverse effects is not a specific indicator of epoetin alfa effectiveness. Iron therapy is usually prescribed to treat iron deficiency anemia, not anemia due to CKD.